Summary
The cytotoxicity, metabolism, and DNA alkylation of porfiromycin (PFM) under aerobic and hypoxic conditions were evaluated in P388 murine leukemia cells. Clonogenic assays showed that the IC50 value for a 1-h exposure to PFM was 4 μm for aerobic cells and 0.5 μm for hypoxic cells. After a 1-h exposure to concentrations of 1.5, and 10 μm [14C]-PFM, the accumulation of total radioactivity in hypoxic cells was 10 to 20 times that in aerobic cells. The disposition of radioactivity in cells that had been treated for 1 h with 5 μm PFM under aerobic or hypoxic conditions showed that (a) under either condition, internal free-PFM concentration equalled the external drug concentration; (b) DNA-, RNA-, and protein-bound radioactivity were at least 10 times greater in hypoxic cells than in aerobic cells; and (c) known metabolites and unidentified radioactive products were also generated in greater amounts in hypoxic cells than in aerobic cells. thus, the increased amounts of radioactivity accumulated by hypoxic P388 cells after exposure to [14C]-PFM resulted from the accumulation of nonexchangeable protein and nucleic-acid adducts and metabolites rather than free PFM. Determinations of DNA adducts formed in P388 cells revealed five possible adducts: (1) N2-(2′-deoxyguanosyl)-7-methylaminomitosene, (2) a second monofunctional PFM-guanine adduct, (3) a PFM cross-linked dinucleotide, (4) possibly a nucleoprotein-related adduct, and (5) an unknown. We conclude that the enhancement of PFM-induced cytotoxicity by hypoxia appears to be primarily due to increased alkylation of macromolecules.
Similar content being viewed by others
Abbreviations
- MMC :
-
mitomycin C
- PFM :
-
porfiromycin
- t-AHME :
-
trans-7-amino-1-hydroxy-2-methylaminomitosenet
- c-AHME :
-
cis-7-amino-1-hydroxy-2-methylaminomitosene
- AME :
-
7-amino-2-methylaminomitosene
- N2-GM :
-
N2-(2′-deoxyguanosyl)-7-amino-1-methylaminomitosene
- PBS :
-
phosphate-buffered saline
- PK :
-
proteinase K
References
Andrews PA, Pan S, Bachur NR (1986) Electrochemical reductive activation of mitomycin C. J Am Chem Soc 108:4158
Bachur N, Gordon S, Gee MV (1978) A general mechanism of microsomal activation of quinone anticancer agents to free radicals. Cancer Res 38:1745
Begleiter A, Blair GW (1984) Quinone-induced DNA damage and its relationship to antitumor activity in L5178Y lymphoblasts. Cancer Res 44:78
Chello PL, Sirotnak FM, Dorick DM, Yang C-H, Montgomery JA (1983) Initial rate kinetics and evidence of duality of mediated transport of adenosine, related purine nucleosides, and nucleoside analogues in L1210 cells. Cancer Res 43:97
Ernster L (1963) DT-disphorase. Methods Enzymol 10:309
Hamburger AW, Salmon SE (1977) Primary bioassay of human tumor stem cells. Science 197:461
Hissin PJ, Hilf R (1978) Characteristics of proline transport into R3230AC mammary tumor cells. Biochim Biophys Acta 508:401
Ivanovic V, Geacimtov NE, Weinstein IB (1976) Cellular binding of benzo(a)pyrene to DNA characterized by loci temperature fluroescence. Biochem Biophys Res Commun 70:1172
Iyer VN, Szybalski W (1963) A molecular mechanism of mitomycin action: linking of complementary DNA strands. Proc Natl Acad Sci USA 50:355
Iyer NV, Szybalski W (1964) Mitomycin and porfiromycin: chemical mechanism of action and cross-linking of DNA. Science 145:55
Kennedy KA, Rockwell S, Satorelli AC (1980) Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res 40:2356
Keyes SR, Rockwell S, Sartorelli AC (1985) Porfiromycin as a bioreductive alkylating agent with selective toxicity to hypoxic EMT6 tumor cells in vivo and in vitro. Cancer Res 45:3642
Keyes SR, Rockwell S, Sartorelli AC (1987) Correlation between drug uptake and selective toxicity of porfiromycin to hypoxic EMT6 cells. Cancer Res 47:5654
Lown JW (1983) The mechanism of action of quinone antibiotics. Mol Cell Biochem 55:17
Marshall RS, Rauth AM (1986) Modification of the cytotoxic activity of mitomycin C by oxygen and ascorbic acid in Chinese hamster ovary cells and repair-deficient mutant. Cancer Res 46:2709
Pan S, Iracki T (1988) Metabolites and DNA adduct formation from flavoenzyme activated porfiromycin. Mol Pharmacol 34:223
Pan S, Andrews P, Glover C, Bachur NR (1984) Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH cytochrome P-450 reductase and xanthine oxidase. J Biol Chem 259:959
Pan S, Iracki T, Bachur NR (1986) DNA alkylation by enzyme-activated mitomycin C. Mol Pharmacol 29:622
Pan S, Iracki T, Bachur NR (1986) Uptake and efflux of [14C]-profiromycin in aerobic and hypoxic P388 murine leukemia cells. Proc Am Assoc Cancer Res 27:234
Pan S, Johnson R, Gonzalez H, Thohan V (1989) Mechanism of transport and intracellular binding of profiromycin in HCT 116 human colon carcinoma cells. Cancer Res 49:5048
Pederson TC, Aust SD (1970) Aminopyrine demethylase: kinetic evidence for multiple microsomal activities. Biochem Pharmacol 19: 2221
Peterson DM, Fisher J (1986) Autocatalytic quinone methide formation from mitomycin C. Biochemistry 25:4077
Rauth AM, Mohindra JK, Tannock IF (1983) Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Cancer Res 43: 4154
Rubin RL, Moudrinakis EN (1975) The F3-F2al complex as a unit in the self-assembly of nucleoproteins. Biochemistry 14:1718
Steven CL, Taylor KG, Munk ME, Marshall WS, Noll K, Shah GD, Shah LG, Uzu K (1964) Chemistry and structure of mitomycin C. J Med Chem 8:1
Tomasz M, Lipman R (1981) Reductive mechanism and alkylating activity of mitomycin C induced by rat liver microsomes. Biochemistry 20:5056
Tomasz M, Lipman R, Snyder JK, Nakanishi K (1983) Full structure of a mitomycin C dinucleotide phosphate adduct. Use of differential FT-IR spectroscopy in microscale structural studies. J Am Chem Soc 105:2059
Tomasz M, Lipman R, Verdine GL, Nakanishi K (1986) Reassignment of the guanine-binding mode of reduced mitomycin C. Biochemistry 25:4337
Tomasz M, Chowdary D, Lipman R, Shimotakahara S, Veiro D, Walker V, Verdine G (1986) Reaction of DNA with chemically or enzymatically activated mitomycin C: isolation and structure of the major covalent adduct. Proc Natl Acad Sci USA 83:6702
Tomasz M, Lipman R, Chowdary D, Pawlak J, Verdine GL, Nakanishi K (1987) Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science 235:1204
Tomasz M, Keyes SR, Lipman R, Hughes CS, Chowdary D, Sartorelli AC (1990) Porfiromycin-DNA adducts isolated from aerobic and hypoxic EMTG tumor cells. Am Assoc Cancer Res 31:394
Weissbach A, Lisio A (1965) Alkylation of nucleic acids by mitomycin C and porfiromycin. Biochemistry 4:196
Workman P, Walton MI, Powis G, Schlager JJ (1989) DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs? Br J Cancer 60:800
Yasukochi Y, Masters BSS (1976) Some properties of detergent-solubilized NADPH-cytochrome C (cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem 251: 5337
Author information
Authors and Affiliations
Additional information
This work was supported by grant CH-412 from the American Cancer Society, grant CA 33 697 from the National Institutes of Health, and an award from the Bressler fund of the School of Medicine at the University of Maryland
Rights and permissions
About this article
Cite this article
Pan, SS. Porfiromycin disposition in oxygen-modulated P388 cells. Cancer Chemother. Pharmacol. 27, 187–193 (1990). https://doi.org/10.1007/BF00685711
Issue Date:
DOI: https://doi.org/10.1007/BF00685711